{"id":1457,"date":"2016-09-27T16:52:03","date_gmt":"2016-09-27T20:52:03","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1457"},"modified":"2016-09-27T16:52:03","modified_gmt":"2016-09-27T20:52:03","slug":"secondaries-announced-9-27-2016","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-9-27-2016\/","title":{"rendered":"Secondaries announced 9.27.2016"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n<p>Company:\tIndependence Realty Trust<br \/>\nSymbol:\tIRT<br \/>\nPrice:\t\tLast trade $10.61<br \/>\nTrade Date:\t9\/30<br \/>\nShares:\t25 million<br \/>\nUnderwriter(s)Citigroup<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tFoamix Pharmaceuticals Ltd.<br \/>\nSymbol:\tFOMX<br \/>\nPrice:\t\tLast trade $9.79<br \/>\nDescription:\tNo re-offer range available<br \/>\nTrade Date:\t9\/28<br \/>\nShares:\t5.1 million<br \/>\nUnderwriter(s)Barclays, Credit Suisse, Cowen &#038; Co., Guggenheim Securities<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tArray Biopharma<br \/>\nSymbol:\tARRY<br \/>\nPrice:\t\tLast trade $6.59<br \/>\nDescription:\t$6.00-$6.50<br \/>\nTrade Date:\t9\/28<br \/>\nShares:\t15.2 million<br \/>\nUnderwriter(s)J.P. Morgan, Cowen &#038; Co.<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:\tVersartis<br \/>\nSymbol:\tVSAR<br \/>\nPrice:\t\tLast trade $13.33<br \/>\nDescription:\tNo re-offer range available<br \/>\nTrade Date:\t9\/28<br \/>\nShares:\tTBD<br \/>\nUnderwriter(s)Cowen &#038; Co., Barclays, Piper Jaffray<br \/>\nCo Manager(s)Canaccord Genuity, SunTrust Robinson Humphrey<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Independence Realty Trust Symbol: IRT Price: Last trade $10.61 Trade Date: 9\/30 Shares: 25 million Underwriter(s)Citigroup Rating=Subscription Needed Company: Foamix Pharmaceuticals[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[906,307,905,16],"class_list":["post-1457","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-arry","tag-fomx","tag-irt","tag-vsar"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1457"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1457\/revisions"}],"predecessor-version":[{"id":1458,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1457\/revisions\/1458"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}